Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04972318
Other study ID # stamina_trial
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date September 4, 2021
Est. completion date September 21, 2023

Study information

Verified date June 2023
Source Hospital do Coracao
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized Controlled Trial Comparing Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia. The control strategy will be based on ARDSNet approach. The intervention group will receive a different ventilatory strategy based on positive end-expiratory pressure tailored according to compliance and limited driving pressure.


Description:

There is no consensus on the optimal ventilatory management of patients with community-acquired pneumonia that require mechanical ventilation and have acute respiratory distress syndrome. The traditional ventilatory approach (ARDSNet) is based on a fixed table for both end respiratory positive end-expiratory pressure according to inspired oxygen fraction. Alternatively, a strategy that tailors positive end-expiratory pressure according to compliance and limits driving pressure may be beneficial, but evidence is lacking. We will perform an open label randomized controlled trial comparing both strategies.


Recruitment information / eligibility

Status Terminated
Enrollment 214
Est. completion date September 21, 2023
Est. primary completion date September 9, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with community acquired pneumonia requiring invasive mechanical ventilation - Bilateral pulmonary infiltrates on chest imaging not fully explained by fluid overload in the opinion of the attending physician - One of the criteria below: - Oxygen inspired fraction above 50% with a positive end-expiratory pressure of at least 8 cmH2O to main peripheral oxygen saturation above 93%, OR - Arterial partial pressure of oxygen divided by inspired fraction of oxygen lower than 200 with PEEP values of at least 5 cmH2O Exclusion Criteria: - Patients with inclusion criteria for more than 36 hours - Refusal of the patient´s legal representative - Acute neurologic disease (stroke, brain trauma, or any disease that may cause intracranial hypertension) - Patients with current airway fistula or barotrauma - Patients on chronic home use of oxygen due to underlying lung disease - Patients younger than 18 years - Patients not on full code status

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Positive end-expiratory pressure titration with driving pressure control
Positive end-expiratory pressure will be tailored during a decremental maneuver (without a formal alveolar recruitment maneuver). The best positive end-expiratory pressure will be defined as the one associated with the higher respiratory system compliance, up to 20 cmH2O. Plateau pressure limit will be 30 cmH2O. If driving pressure remains elevated after optimal PEEP setting, tidal volume will be reduced to keep driving pressure below 14 cmH2O.
ARDSNet ventilatory strategy
Positive end-expiratory pressure will be set according to fixed inspired oxygen fraction values.

Locations

Country Name City State
Brazil Hospital São José Criciuma SC
Brazil Hospital Nereu Ramos Florianópolis Sc
Brazil Centro Hospitalar Unimed Joinville SC
Brazil Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina Londrina PR
Brazil BP-A Beneficiência Portuguesa de São Paulo São Paulo
Brazil Hospital do Coracao São Paulo

Sponsors (2)

Lead Sponsor Collaborator
Hospital do Coracao Brazilian Research In Intensive Care Network

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Oxygenation parameters (oxygenation index and fraction of arterial pressure of oxygen over inspired oxygen fraction) Measurements of oxygenation in the first 3 days after enrollment (ratio between arterial partial pressure of oxygen over inspired fraction of oxygen, and oxygenation index, defined by mean airway pressure multiplied by fraction of inspired oxygen over arterial partial pressure of oxygen. 3 days
Other Driving Pressure during mechanical ventilation Driving pressured, measured once daily and defined by airway plateau pressure minus positive end-expiratory pressure 3 days
Other Intensive Care Unit Free Days Number of days the patient spend alive and out of the intensive care unit 28 days
Other Ventilatory Rate Ventilatory Rate, measured daily, defined as minute ventilation (in liters) multiplied by arterial partial pressure of oxygen, divided by 37.5 multiplied by patient weight (in kilograms) multiplied by 100 3 days
Primary Mechanical ventilation free days Number of days patient remains independent of mechanical ventilation 28 days
Secondary Hospital Mortality Whether the patient perished or not during hospitalization 90 days
Secondary Intensive Care Unit Mortality Whether the patient perished or not during intensive care unit stay, truncated at 28 days 90 days
Secondary Need for rescue therapies for refractory hypoxemia Need for extracorporeal membrane oxygenation, alveolar recruitment maneuver, or inhaled nitroux oxide, truncated at 28 days 28 days
Secondary Occurrence of barotrauma Occurrence of either subcutaneous emphysema, pneumothorax or pneumatocele, truncated at 28 days 28 days
See also
  Status Clinical Trial Phase
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Recruiting NCT05535543 - Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
Completed NCT04695392 - Restore Resilience in Critically Ill Children N/A
Completed NCT04534569 - Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
Completed NCT04078984 - Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
Completed NCT04451291 - Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure N/A
Not yet recruiting NCT06254313 - The Role of Cxcr4Hi neutrOPhils in InflueNza
Not yet recruiting NCT04798716 - The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 Phase 1/Phase 2
Withdrawn NCT04909879 - Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome Phase 2
Not yet recruiting NCT02881385 - Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation N/A
Terminated NCT02867228 - Noninvasive Estimation of Work of Breathing N/A
Completed NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Completed NCT02232841 - Electrical Impedance Imaging of Patients on Mechanical Ventilation N/A
Withdrawn NCT02253667 - Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients N/A
Completed NCT01504893 - Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia N/A
Completed NCT02889770 - Dead Space Monitoring With Volumetric Capnography in ARDS Patients N/A
Withdrawn NCT01927237 - Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide N/A
Completed NCT02814994 - Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients N/A
Completed NCT01680783 - Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure N/A
Completed NCT02214576 - High Flow Nasal Canula Oxygen Helps Preoxygenate ARDS Patients N/A